Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2010
10/14/2010US20100260674 Quinazoline derivatives and methods of treatment
10/14/2010US20100260669 Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
10/14/2010US20100260668 Dual Variable Domain Immunoglobulins and Uses Thereof
10/14/2010US20100260667 Vimentin Directed Diagnostics And Therapeutics For Multidrug Resistant Neoplastic Disease
10/14/2010CA2787099A1 Influenza virus vaccines and uses thereof
10/14/2010CA2762187A1 New methods for treatment of inflammatory diseases
10/14/2010CA2758204A1 Immunogenic composition and uses thereof
10/14/2010CA2757986A1 Non-pegylated liposomal doxorubicin triple combination therapy
10/14/2010CA2757941A1 Therapeutic agent for diseases in which neoplastic proliferation of plasma cells occurs
10/14/2010CA2757933A1 Method for treating immune disorders
10/14/2010CA2757931A1 Trivalent, bispecific antibodies
10/14/2010CA2757895A1 Method for purifying the rabies virus
10/14/2010CA2757828A1 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
10/14/2010CA2757680A1 Therapeutic agents for the treatment of diseases associated with undesired cell proliferation
10/14/2010CA2757669A1 Bispecific anti-erbb-1/anti-c-met antibodies
10/14/2010CA2757345A1 Pharmaceutical composition
10/14/2010CA2757287A1 Cytokines and neuroantigens for treatment of immune disorders
10/14/2010CA2757104A1 Antibodies against il-17br
10/14/2010CA2756245A1 Antibodies against human tweak and uses thereof
10/14/2010CA2754807A1 Combination therapy of an afucosylated antibody and one or more of the cytokines selected from human gm-csf, human m-csf and/or human il-3
10/14/2010CA2754408A1 Fusion proteins comprising canine fc portions
10/14/2010CA2750836A1 Anti-siglec-15 antibody
10/13/2010EP2239340A2 Identification of surface-oriented antigens for tumour diagnosis and treatment
10/13/2010EP2239323A1 Humanized anti-human 9-integrin antibody
10/13/2010EP2239321A1 Clearance of ras-mediated neoplastic cells from mixed cellular compositions using reovirus
10/13/2010EP2239271A1 Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereof
10/13/2010EP2239269A1 Use of peptides derived from copolymer-1 as molecular weight markers
10/13/2010EP2238986A2 Sp35 antibodies and uses thereof
10/13/2010EP2238985A1 High concentration antibody-containing liquid formulation
10/13/2010EP2238253A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
10/13/2010EP2238173A1 Bivalent, bispecific antibodies
10/13/2010EP2238172A1 Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof
10/13/2010EP2238170A1 Antibodies against human cd39 and use thereof for inhibiting t regulatory cells activity
10/13/2010EP2238166A2 Use of anti-amyloid beta antibody in ocular diseases
10/13/2010EP2238160A1 Multimeric proteins able to induce an antibody response against the beta-amyloid and use thereof
10/13/2010EP2238079A2 Method and apparatus for increasing contaminant clearance rates during extracorporeal fluid treatment
10/13/2010EP2237797A2 Antibody targeting through a modular recognition domain
10/13/2010EP2237792A1 Anti-c35 antibody combination therapies and methods
10/13/2010EP1656391B1 Modified human igf-1r antibodies
10/13/2010EP1625393B1 Vaccines conferring protection to infection by Streptococcus pneumonia.
10/13/2010EP1503785B1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
10/13/2010EP1421178B1 Improved methods for producing oocysts
10/13/2010EP1381631B1 Human anti timp-1 antibodies
10/13/2010EP1102848B1 Molecules designated ldcam
10/13/2010CN1953768B Highly concentrated liquid formulations of anti-EGFR antibodies
10/13/2010CN1909925B Immunologic adjuvant
10/13/2010CN1563088B Specific composite IgY for anti influenza and preparation
10/13/2010CN1395581B Recombinant antibodies to human IL-1 beta
10/13/2010CN101861336A Human GM-CSF antigen binding proteins
10/13/2010CN101861331A Hypoallergenic variants of the major allergen from betula verrucosa pollen
10/13/2010CN101861168A Anti-ICOS antibodies and their use in treatment of oncology, transplantation and autoimmune disease
10/13/2010CN101861167A Vaccine comprising monocyte or immature myeloid cells(IMC) which were loaded with the ligand of natural killer t cell and antigen
10/13/2010CN101861166A Agent exhibiting properties to form the cellular immunity against mycobacterium tuberculosis H37 Rv, method for the production thereof (variants), a recombinant strain and an agent for tuberculosis diagnosis
10/13/2010CN101861165A Vaccine nanotechnology
10/13/2010CN101861164A Treatment of prion protein related diseases
10/13/2010CN101861163A Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods
10/13/2010CN101861159A Improved antitumoral treatments
10/13/2010CN101857861A Molecular marker for immunological recognition and construction and application thereof
10/13/2010CN101857636A Anti-interferon-alpha antibodies
10/13/2010CN101856497A Conjugate of hapten and amino-containing carrier and preparation method and usage thereof
10/13/2010CN101856496A Placenta stem-cell anti-tumor vaccine, preparation method and application thereof
10/13/2010CN101280292B Virus velogen strain for porcine reproductive and respiratory syndrome, attenuated vaccine strain thereof and application thereof
10/13/2010CN101245107B Antihuman transferrin acceptor human source antibody and uses thereof
10/13/2010CN101134772B Method for separating membrane protein of sucking sperm rear head and uses thereof
10/12/2010US7812147 nucleic acid that encodes a Lactoferrin binding protein; for use in diagnosis, treatment and prevention of streptococcal pathogen infection; strep throat, scarlet fever, and rheumatic fever; mastitis
10/12/2010US7812136 useful for monitoring the (de)activation status if the patient is treated with thrombocyte aggregation inhibitors
10/12/2010US7812135 GITR-binding antibodies
10/12/2010US7812134 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
10/12/2010US7812133 Anti-OX40L antibodies and methods using same
10/12/2010US7812129 Unique novel Bacillus thuringiensis gene with lepidopteran activity
10/12/2010US7812116 Immunogenic peptides
10/12/2010US7812000 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
10/12/2010US7811990 Using tumor necrosis factor modulators/inhibitors as tool in treatment and prevention of spinal cord injury
10/12/2010US7811985 Treatment and prophylaxis of reperfusion injuries, particularly after cardiac necrosis; administering an N-terminus modified polypeptide derived from the A alpha chain of fibrinand the B beta chain of fibrin; antiinflammatory agents
10/12/2010US7811983 Increased T-cell tumor infiltration and eradication of metastases by mutant light
10/12/2010US7811973 Phage display technologies
10/12/2010US7811832 Administering an apoptosis inhibitor to a mammal having an eye with retinal detachment
10/12/2010US7811816 Isolated CD8 +T lymphocytes specifically cytotoxic for a disease causing target cell
10/12/2010US7811812 For use in gene therapy and recombinant protein production
10/12/2010US7811791 nucleic acid ; for diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IFN-L polypeptides
10/12/2010US7811770 Method of detecting a subfraction of proBNP
10/12/2010US7811592 For immunizing an animal
10/12/2010US7811591 comprising non-typeable H. influenzae (NTHi) twitching pilus major subunit protein; otitis media, pneumonia, sinusitis, septicemia, endocarditis, epiglottitis, septic arthritis, meningitis, sepsis, salpingitis, epiglottis, pericardis, cellulitis, osteomyelitis, endocarditis, cholecystitis
10/12/2010US7811590 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system
10/12/2010US7811589 Method for stimulating immune response against Moraxella catarrhalis
10/12/2010US7811588 Therapeutic agent for treatment and prevention of bacterial infections; immunoassay
10/12/2010US7811587 Botulinum toxin therapy for neuropsychiatric disorders
10/12/2010US7811586 Methods for alleviating testicular pain
10/12/2010US7811585 Streptococcus pyogenes antigens
10/12/2010US7811584 prevent exocytosis and secretion by target cell; enzymatic domain, binding domains, translocation domain, protease cleavage site; disorders of sensory or motor nervous system, acute or chronic pain, cancer, pancreatitis, hyperhydrosis, glandular disorders, viral infections, cystic fibrosis
10/12/2010US7811583 septicemia; chimera; var proteins from Infectious Pancreatic Necrosis virus; antigen obtained from Aeromonas salmonicida
10/12/2010US7811582 Herpes viruses for immune modulation
10/12/2010US7811581 immunogens; tumor antigens; devoid of immunosuppressive domain; fusion proteins; immunotherapy
10/12/2010US7811580 Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes
10/12/2010US7811579 Full-length genomic RNA of Japanese encephalitis virus, infectious JEV cDNA therefrom, and use thereof
10/12/2010US7811578 Soluble chimeric peptide inhibitors of HIV entry comprising an IZ trimeric coiled-coil peptide and HIV gp41 N-helix coiled-coil peptide
10/12/2010US7811577 Covalently stabilized chimeric coiled-coil HIV gp41 N-peptides with improved antiviral activity
10/12/2010US7811576 Composition comprising hepadnavirus core antigen for use in preparing vaccines against hepatitis infection
10/12/2010US7811575 Diagnosis by detecting overexpression; active or passive immunization; antibodies, transgenic animals, hybridoma
10/12/2010US7811574 prophylaxis and diagnosis of neoplastic growth by administering polypeptides and polynucleotides, variants, fragments and fusion proteins, to induce immunogenic response tumor antigens; immunology
1 ... 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 ... 1823